2017-2022 North America Drugs for Malaria Market Report

November 2017 | 112 pages | ID: 2CCC39E2425EN
LP Information

Abstracts

In 2016, the North America Drugs for Malaria market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

This report studies Drugs for Malaria in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

Market Segment by Countries, this report splits North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast), like

• United States
• Canada
• Mexico

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Malaria in each application, can be divided into

• Prevention
• Treatment
• Other

Contents

1 DRUGS FOR MALARIA MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs for Malaria
1.2 Drugs for Malaria Segment by Types
  1.2.1 North America Sales Market Share of Drugs for Malaria by Types in 2016
  1.2.2 Aryl Aminoalcohol Compounds
    1.2.2.1 Major Players of Aryl Aminoalcohol Compounds
  1.2.3 Antifolate Compounds
    1.2.3.1 Major Players of Antifolate Compounds
  1.2.4 Artemisinin Compounds
    1.2.4.1 Major Players of Artemisinin Compounds
1.3 Drugs for Malaria Segment by Applications
  1.3.1 Drugs for Malaria Sales Market Share by Applications in 2016
  1.3.2 Prevention
  1.3.3 Treatment
  1.3.4 Other
1.4 Drugs for Malaria Market by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Canada Status and Prospect (2012-2022)
  1.4.3 Mexico Status and Prospect (2012-2022)
1.5 North America Drugs for Malaria Overview and Market Size (Value) (2012-2022)
  1.5.1 North America Market Drugs for Malaria Overview
  1.5.2 North America Market Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

2 NORTH AMERICA DRUGS FOR MALARIA SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 North America Drugs for Malaria Sales and Market Share in 2016 and 2017 by Players
2.2 North America Drugs for Malaria Revenue and Market Share by Players in 2016 and 2017
2.3 North America Drugs for Malaria Average Price by Players in 2016 and 2017
2.4 North America Drugs for Malaria Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Drugs for Malaria Market Competitive Situation and Trends
  2.5.1 Drugs for Malaria Market Concentration Rate
  2.5.2 Drugs for Malaria Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 NORTH AMERICA DRUGS FOR MALARIA SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)

3.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries (2012-2017)
  3.1.1 North America Drugs for Malaria Sales and Market Share by Countries (2012-2017)
  3.1.2 North America Drugs for Malaria Revenue and Market Share by Countries (2012-2017)
  3.1.3 North America Drugs for Malaria Price by Countries (2012-2017)
3.2 North America Drugs for Malaria Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.2.1 North America Drugs for Malaria Sales and Market Share by Type (2012-2017)
  3.2.2 North America Drugs for Malaria Revenue and Market Share by Type (2012-2017)
  3.2.3 North America Drugs for Malaria Price by Type (2012-2017)
3.3 North America Drugs for Malaria Sales and Market Share by Application (2012-2017)
3.4 North America Market Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)

4 NORTH AMERICA DRUGS FOR MALARIA PLAYERS PROFILES/ANALYSIS

4.1 Cipla
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Drugs for Malaria Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Cipla News
4.2 Guilin Pharmaceutical
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Drugs for Malaria Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Guilin Pharmaceutical News
4.3 IPCA Laboratories
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Drugs for Malaria Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 IPCA Laboratories News
4.4 GlaxoSmithKline
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Drugs for Malaria Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 GlaxoSmithKline News
4.5 Mylan Labs
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Drugs for Malaria Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 Mylan Labs News
4.6 Roche
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Drugs for Malaria Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Roche News
4.7 Novartis
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Drugs for Malaria Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 Novartis News
4.8 Sanofi Aventis
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Drugs for Malaria Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview
  4.8.5 Sanofi Aventis News
4.9 Ajanta Pharma
  4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.9.2 Drugs for Malaria Product Types, Application and Specification
    9.9.2.1 Type
    9.9.2.2 Type
  4.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  4.9.4 Main Business/Business Overview
  4.9.5 Ajanta Pharma News

5 UNITED STATES DRUGS FOR MALARIA SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

5.1 United States Drugs for Malaria Sales, Revenue and Growth Rate (2012-2017)
5.2 United States Drugs for Malaria Sales, Revenue and Market Share by Type (2012-2017)
  5.2.1 United States Drugs for Malaria Sales and Market Share by Type (2012-2017)
  5.2.2 United States Drugs for Malaria Revenue and Market Share by Type (2012-2017)
  5.2.3 United States Drugs for Malaria Price by Type (2012-2017)
5.3 United States Drugs for Malaria Sales and Market Share by Application (2012-2017)

6 CANADA DRUGS FOR MALARIA SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

6.1 Canada Drugs for Malaria Sales, Revenue and Growth Rate (2012-2017)
6.2 Canada Drugs for Malaria Sales, Revenue and Market Share by Type (2012-2017)
  6.2.1 Canada Drugs for Malaria Sales and Market Share by Type (2012-2017)
  6.2.2 Canada Drugs for Malaria Revenue and Market Share by Type (2012-2017)
  6.2.3 Canada Drugs for Malaria Price by Type (2012-2017)
6.3 Canada Drugs for Malaria Sales and Market Share by Application (2012-2017)

7 MEXICO DRUGS FOR MALARIA SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

7.1 Mexico Drugs for Malaria Sales, Revenue and Growth Rate (2012-2017)
7.2 Mexico Drugs for Malaria Sales, Revenue and Market Share by Type (2012-2017)
  7.2.1 Mexico Drugs for Malaria Sales and Market Share by Type (2012-2017)
  7.2.2 Mexico Drugs for Malaria Revenue and Market Share by Type (2012-2017)
  7.2.3 Mexico Drugs for Malaria Price by Type (2012-2017)
7.3 Mexico Drugs for Malaria Sales and Market Share by Application (2012-2017)

8 NORTH AMERICA DRUGS FOR MALARIA MARKET FORECAST (2017-2022)

8.1 North America Drugs for Malaria Sales, Revenue Forecast (2017-2022)
8.2 North America Drugs for Malaria Sales, Sales Forecast by Countries (2017-2022)
8.3 North America Drugs for Malaria Sales Forecast by Type (2017-2022)
8.4 North America Drugs for Malaria Sales Forecast by Application (2017-2022)
8.5 Drugs for Malaria Price Forecast (2017-2022)

9 DRUGS FOR MALARIA MANUFACTURING COST ANALYSIS

9.1 Drugs for Malaria Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Drugs for Malaria

10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Drugs for Malaria Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Drugs for Malaria Major Players in 2016
10.4 Downstream Buyers

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Malaria
Table Product Specifications of Drugs for Malaria
='Figure North America Sales Market Share of '&Sheet1!B1&' by Types in 2016
Table Types of Drugs for Malaria
Figure Product Picture of Aryl Aminoalcohol Compounds
Table Major Players of Aryl Aminoalcohol Compounds
Figure Product Picture of Antifolate Compounds
Table Major Players of Antifolate Compounds
Figure Product Picture of Artemisinin Compounds
Table Major Players of Artemisinin Compounds
Figure Drugs for Malaria Sales Market Share by Applications in 2016
='Table Applications of '&Sheet1!B1&'
Figure Prevention Examples
Figure Treatment Examples
Figure Other Examples
Figure United States Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure North America Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Table North America Drugs for Malaria Sales by Players in 2016 and 2017
Table North America Drugs for Malaria Sales Market Share (%) by Players in 2016 and 2017
Figure North America Drugs for Malaria Sales Market Share by Players in 2016
Figure North America Drugs for Malaria Sales Market Share by Players in 2017
Table North America Drugs for Malaria Revenue by Players in 2016 and 2017
Table North America Drugs for Malaria Revenue Market Share (%) by Players in 2016 and 2017
Figure North America Drugs for Malaria Revenue Market Share by Players in 2016
Figure North America Drugs for Malaria Revenue Market Share by Players in 2017
Table North America Drugs for Malaria Average Price by Players in 2016 and 2017
Figure North America Drugs for Malaria Average Price by Players in 2016
Table North America Drugs for Malaria Manufacturing Base Distribution and Sales Area by Players
Table Players Drugs for Malaria Product Types
Figure Drugs for Malaria Market Share of Top 3 Players
Figure Drugs for Malaria Market Share of Top 5 Players
Table North America Drugs for Malaria Sales by Countries (2012-2017)
Table North America Drugs for Malaria Sales Market Share by Countries (2012-2017)
Figure North America Drugs for Malaria Sales Market Share by Countries (2012)
Figure North America Drugs for Malaria Sales Market Share by Countries (2016)
Table North America Drugs for Malaria Revenue by Countries (2012-2017)
Table North America Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Figure 2012 North America Drugs for Malaria Revenue Market Share by Countries
Figure 2016 North America Drugs for Malaria Revenue Market Share by Countries
Table North America Drugs for Malaria Price by Countries (2012-2017)
Table North America Drugs for Malaria Sales by Type (2012-2017)
Table North America Drugs for Malaria Sales Market Share by Type (2012-2017)
Figure 2012 North America Drugs for Malaria Sales Market Share by Type
Figure 2016 North America Drugs for Malaria Sales Market Share by Type
Table North America Drugs for Malaria Revenue by Type (2012-2017)
Table North America Drugs for Malaria Revenue Market Share by Type (2012-2017)
Figure 2012 North America Drugs for Malaria Revenue Market Share by Type
Figure 2016 North America Drugs for Malaria Revenue Market Share by Type
Table North America Drugs for Malaria Price by Type (2012-2017)
Table North America Drugs for Malaria Sales by Application (2012-2017)
Table North America Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure North America Drugs for Malaria Sales Market Share by Application (2012-2017)
Table North America Market Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cipla Drugs for Malaria Market Share (2012-2017)
Table Guilin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Market Share (2012-2017)
Table IPCA Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Market Share (2012-2017)
Table Mylan Labs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Labs Drugs for Malaria Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Drugs for Malaria Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Drugs for Malaria Market Share (2012-2017)
Table Sanofi Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Aventis Drugs for Malaria Market Share (2012-2017)
Table Ajanta Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Market Share (2012-2017)
Figure United States Drugs for Malaria Sales and Growth Rate (2012-2017)
Figure United States Drugs for Malaria Revenue and Growth Rate (2012-2017)
Table United States Drugs for Malaria Sales by Type (2012-2017)
Table United States Drugs for Malaria Sales Market Share by Type (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Type (2012-2017)
Table United States Drugs for Malaria Revenue by Type (2012-2017)
Table United States Drugs for Malaria Revenue Market Share by Type (2012-2017)
Figure United States Drugs for Malaria Revenue Market Share by Type (2012-2017)
Table United States Drugs for Malaria Price by Type (2012-2017)
Table United States Drugs for Malaria Sales by Application (2012-2017)
Table United States Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure Canada Drugs for Malaria Sales and Growth Rate (2012-2017)
Figure Canada Drugs for Malaria Revenue and Growth Rate (2012-2017)
Table Canada Drugs for Malaria Sales by Type (2012-2017)
Table Canada Drugs for Malaria Sales Market Share by Type (2012-2017)
Figure Canada Drugs for Malaria Sales Market Share by Type (2012-2017)
Table Canada Drugs for Malaria Revenue by Type (2012-2017)
Table Canada Drugs for Malaria Revenue Market Share by Type (2012-2017)
Figure Canada Drugs for Malaria Revenue Market Share by Type (2012-2017)
Table Canada Drugs for Malaria Price by Type (2012-2017)
Table Canada Drugs for Malaria Sales by Application (2012-2017)
Table Canada Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure Canada Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure Mexico Drugs for Malaria Sales and Growth Rate (2012-2017)
Figure Mexico Drugs for Malaria Revenue and Growth Rate (2012-2017)
Table Mexico Drugs for Malaria Sales by Type (2012-2017)
Table Mexico Drugs for Malaria Sales Market Share by Type (2012-2017)
Figure Mexico Drugs for Malaria Sales Market Share by Type (2012-2017)
Table Mexico Drugs for Malaria Revenue by Type (2012-2017)
Table Mexico Drugs for Malaria Revenue Market Share by Type (2012-2017)
Figure Mexico Drugs for Malaria Revenue Market Share by Type (2012-2017)
Figure 2016 Mexico Drugs for Malaria Revenue Market Share by Type
Table Mexico Drugs for Malaria Price by Type (2012-2017)
Table Mexico Drugs for Malaria Sales by Application (2012-2017)
Table Mexico Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure Mexico Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure North America Drugs for Malaria Sales and Growth Rate Forecast (2017-2022)
Figure North America Drugs for Malaria Revenue and Growth Rate Forecast (2017-2022)
Table North America Drugs for Malaria Sales Forecast by Countries (2017-2022)
Table North America Drugs for Malaria Sales Market Share Forecast by Countries (2017-2022)
Table North America Drugs for Malaria Sales Forecast by Type (2017-2022)
Table North America Drugs for Malaria Sales Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Malaria
Figure Manufacturing Process Analysis of Drugs for Malaria
Figure Drugs for Malaria Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Malaria Major Players in 2016
Table Major Buyers of Drugs for Malaria
Table Distributors/Traders List